Work

Epichaperome-targeted myocardial imaging by 124I-PU-H71 PET

Year: 2024

Type: article

Source: Clinical and Translational Imaging

DOI: 10.1007/s40336-024-00658-9

Authors: Sonia Mahajan, Milan Grkovski, Kevin D. Staton, Susana Ravassa, Kwaku Domfe, H. William Strauss, John L. Humm, Pat B. Zanzonico, Bradley J. Beattie, Insang Cho, Eva M. Burnazi, Josef J. Fox, Heiko Schöder, Joseph R. Osborne, Trisha Youn, Komal Jhaveri, Gabriela Chiosis, Mark P. Dunphy

Institutions: Memorial Sloan Kettering Cancer Center, Instituto de Salud Carlos III, Navarre Institute of Health Research, Centro de Investigación Médica Aplicada, Universidad de Navarra, SUNY Upstate Medical University, Weill Cornell Medicine, New York University

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Memorial Sloan-Kettering Cancer Center, National Institutes of Health, National Institute on Aging, National Cancer Institute

Awards: A chemical chaperomics platform for AD, Small molecule Hsp90 inhibitors in AD treatment, Biomarkers for predicting response to Hsp90 therapy, Selective interactome vulnerability across the Alzheimer’s disease spectrum, Cancer Center Support Grant, Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum, Chaperome networks in Alzheimer's disease, Neuropathology and inflammation in a nonhuman primate model of insulin resistance/metabolic syndrome, Selective interactome vulnerability across the Alzheimer’s disease spectrum

OpenAlex ID: W4402694347

FWCI: 0.51

Cites: 30

Cited by: 2

Related to: 10